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Background: Endogenous corticosteroids and endocannabinoids are
both known to be involved in stress adaption and anti-inflammatory
and immuneregulatory effects. The application of hair as retrospective
specimen for long-term recording of corticosteroids and its association
with stress-induced biochemical alterations was intensively examined.
Methods: To evaluate the stability and correlation of various
parameters of the endocannabinoid and corticosteroid systems, a pro-
spective study was carried out. Hair samples were collected monthly
over a pregnancy cycle (sixth week of pregnancy to 9 weeks
postpartum). By comparison of hair concentrations in particular
segments (ie, grown in the same time span but collected at different
times), an examination of analyte stability in hair was achieved.
Additionally, the comparison of proximal segments provided on
biochemical information that is independent of alteration due to
physical instability. The detection limits of a validated procedure using
solid-phase extraction cleanup and liquid chromatography–mass spec-
trometry proved to be suitable to identify the endogenous levels of
cortisol (limits of detection = 1.6 pg/mg), cortisone (2.1 pg/mg), anan-
damide (AEA, 0.3 pg/mg), and 2-arachidonoylglycerol (15 pg/mg).
Results: Corticosteroid concentrations in corresponding hair seg-
ments were found to be reduced with increasing hair age; an average
decline of cortisol and cortisone by 50% in 4 months was estimated.
Independently, an increase of cortisol and cortisone in proximal
segments collected during pregnancy was confirmed, which is
assumed to be stress related. Endocannabinoids proved to be by
far more stable, as demonstrated by subsequent monthly collection
of corresponding segments and there was hardly any washout
of AEA detectable. Elevated hair concentrations of AEA and
2-arachidonoylglycerol were detected in the first–second trimester
of pregnancy, which corresponds to negative correlations between
AEA, cortisol, and cortisone.
Key Words: corticosteroids, endocannabinoids, hair, pregnancy,
LC–MS/MS
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INTRODUCTION
The endogenous corticosteroids cortisol and cortisone
interact with various biochemical pathways, for example, fat,
protein, and carbohydrate biosyntheses and metabolisms.
Cortisol as a biologically active hormone is responsible for
several highly important physiological actions, for example,
stress adaptation and anti-inflammatory, and immuneregula-
tory effects. The biosynthesis of corticosteroids is affected by
individual situations and circumstances (eg, acute and chronic
stress exposure1–4). Due to its importance in several diseases,
such as the Cushing Syndrome and Morbus Addison, or
enzyme deficiencies, cortisol is commonly used as a diagnos-
tic parameter. During the past years, cortisol and cortisone
were discussed as biomarkers for various chronic stress sit-
uations, for example, depression5 or posttraumatic stress dis-
order.6 Due to the circadian fluctuation of cortisol in blood,
urine, and saliva, caused by a pulsatile release and circadian
rhythm,7 a single concentration value would be unfavorable.
Alternatively to collection of day profiles or a consistent sam-
pling at a certain time of the day, hair samples can be con-
sidered as cumulative specimens. A correlation between hair
concentration of cortisol and chronic stress situation, for
example, depression was shown in multiple studies.8–14 In
contrast, Dowlati et al15 did not find any correlation of hair
cortisol with depression.
In contrast to psychiatric disorders, such as depression
or posttraumatic stress disorder, pregnancy represents a phys-
iologic chronic stress situation. The blood level of cortisol
increases continuously during pregnancy. The highest value
was detected for the third trimester.16–18 Various studies were
concerned with the question whether this increased cortisol
concentration is also detectable in hair.19–21 Compared with
control samples, the cortisol concentrations (measured by
immunoassays) showed the highest values (40–50 pg/mg)
in the proximal segments of hair samples correlated to the
third trimester. Elevated cortisol concentrations were reported
to be detectable up to 3 months after pregnancy.21
The endocannabinoid system is another stress-related
mechanism in human physiology. It consists of several
endogenous ligands (endocannabinoids), their receptors and
various enzymes (eg, fatty acid amid hydrolase), which
regulate their synthesis and degradation. The endocannabi-
noids are natural ligands that bind to the same receptor as
delta-9-tetrahydrocannabinol, mainly the cannabinoid recep-
tors CB1 and CB2.22 The most investigated are anandamide
(AEA; arachidonoyl-ethanolamide)23,24 and 2-arachidonoyl-
glycerol (2AG).24,25 They are important for the regulation of
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various physiological processes, for example, the immune
system and feeding behavior. Endocannabinoids are lipid sig-
naling molecules that are synthesized on demand and rapidly
deactivated resulting in a very short half-life.26 Thereby, they
can quickly react to various acute situations. The endocanna-
binoid system plays an essential role in the regulation of the
hypothalamic–pituitary–adrenal (HPA) axis, and it is there-
fore an important mediator in the response to stress.27 Various
studies demonstrated temporary increases in AEA and 2AG
blood concentrations when humans were exposed to acute
stress situations, for example, kinetic,28 physical,29 and social
stress.30 Measurements of AEA in the blood revealed concen-
tration variations during pregnancy.31–33 In contrast to their
first study,31 Lam et al32 showed that the AEA plasma con-
centrations remained unchanged during the first and second
trimesters and increased during the last 3 months of preg-
nancy. Therefore, pregnancy seems to influence not only
the glucocorticoid but also the endocannabinoid system.
The major response to stress in humans results from the
activation of the HPA axis. Both the corticosteroid and the
endocannabinoid system interact with the HPA axis. Due to
stress, the hypothalamus is activated, and the synthesis of
corticotrophin-releasing hormone is increased. This in turn
stimulates the synthesis of corticotrophin that induces the
production of cortisol in the adrenal cortex. Because of
a negative feedback mechanism, cortisol effects the suppres-
sion of its own production.27,34,35 Endocannabinoids are crit-
ically involved in regulating this inhibitory mechanism.27
A recent study has suggested a negative relationship between
the concentrations of plasma endocannabinoids and the activ-
ity of the HPA axis in stressed humans.36 Several studies in
animals have shown that increased glucocorticoid concentra-
tions in several stress-activated brain areas were associated
with reduced AEA concentrations in these regions.37,38
In this work, a validated analytical method to detect
cortisol, cortisone, AEA, and 2AG in hair samples is
presented. Our study was carried out to determine the changes
in hair concentrations of corticosteroids and endocannabi-
noids during a chronic stress situation and to establish
a possible correlation between these 2 parameters. Pregnancy
was chosen as a model of a chronic stress situation.
Hair samples were self-collected by one of the authors
(P.A.) monthly during pregnancy. This prospective study was
carried out from the sixth week of gestation until 2 months
after childbirth. Thereby, variations of hair concentrations of
corticosteroids and endocannabinoids in proximal segments
could be analyzed serially during pregnancy. Moreover, the
quantitation of all analytes in equivalent segments (ie, grown
at the same time but collected at different times) revealed an




Solvents and chemicals used for hair extraction,
alkaline hydrolysis, solid-phase extraction (SPE), and liquid
chromatography with tandem mass spectrometry (LC–
MS/MS) were methanol, acetonitrile (both gradient grade,
J.T.Baker, Deventer, Netherlands), water (gradient grade,
Fisher scientific, Schwerte, Germany), ammonia (25%, Chem
Solute, Renningen, Germany), and potassium hydroxide pellets
(85%–90%, VWR, Dresden, Germany). Ethylene glycol (J.T.
Baker) was added to samples for reducing evaporation losses of
the analytes. The high-performance liquid chromatography
(HPLC) buffer solutions consist of a mixture of water/acetoni-
trile (A: 95/5 vol/vol; B: 5/95 vol/vol) containing 2 mmole of
ammonium acetate (Merck, Darmstadt, Germany). The follow-
ing reference compounds were used for calibration and valida-
tion: cortisone (Sigma, St Louis, MO); cortisol (Merck); AEA
and 2AG (BioTrend, Zurich, Switzerland). Cortisol-d4 (CIL,
Andover, MA) and AEA-d8 (Cayman Chemicals, Ann
Arbor, MI) were added as the internal standard (IS).
Hair Samples
A blank hair sample was collected from a 54-year-old
woman. Endogenous concentrations of steroid hormones
were not detectable due to longtime hair bleaching.
In the prospective study, 11 hair samples were self-
collected by one of the authors (P.A., 34 years) during her
pregnancy. The first sample was taken in the sixth week of
pregnancy and then every month up to 9 weeks after delivery.
Hair strands, as thick as a pencil, were carefully cut as
close as possible to the scalp from a posterior vertex and were
stored under dry conditions at room temperature. The hair
samples were cut into 4 (or in 2 relevant cases into 5)
segments, 2 cm each.
Sample Preparation
Due to the lack of potential sources of external
contaminations, a washing procedure was not applied. Hair
samples were powdered using an MM301 ball mill (Retsch,
Haan, Germany; 1 minute at 30 Hz), and powdered hair was
weighed (range, 30–80 mg; average, 50 mg). After the addition
of 2.5 ng of cortisol-d4 (d4-C) as IS, extraction with 2.5 mL
methanol was carried out in an ultrasonic bath at 508C for
4 hours. The liquid phase was separated after centrifugation,
and 20 mL of ethylene glycol was added before evaporation
under nitrogen stream at 608C. After reconstitution with 0.5 mL
water, the solution was transferred to SPE columns (Plexa
BondElut, 3 mL, 60 mg; Agilent Technologies, Böblingen,
Germany). SPE was processed by Aspec XL4 (Gilson,
Middleton, WI). SPE columns were preconditioned with 3
mL of methanol and 1 mL of water. After loading, columns
were washed with 2 mL of methanol/2% NH4OH solution
(40/60 vol/vol) and eluted with 2 mL of methanol/water
(90/10 vol/vol). Hair residues from methanolic extraction were
hydrolyzed with 1.5 mL of 0.5 N KOH solution for 8 hours at
808C after the addition of 2.5 ng of AEA-d8 (d8-AEA) as IS.
After separation of the liquid phase, another SPE cleanup was
performed as described above. Extracts from both SPE runs
were combined, evaporated (as described above), and recon-
stituted with 30 mL of HPLC buffer A.
Measurement by LC–MS/MS
Chromatographic separation was operated on the LC
system (Agilent Technologies1200 series) consisting of
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a degasser, a binary pump, a column compartment, and an
autosampler. A 5-mL volume of the reconstituted extract was
injected onto a Hypersil Gold C18-column (100 · 2.1 mm, 3
mm; Thermo Fisher Scientific, Langerwehe, Germany) pro-
tected by a Zorbax Eclipse XDB-C8-fingertight guard cartridge
(2.1 · 12.5 mm, 5 mm; Agilent Technologies). A flow rate of
300 mL/min was used. Chromatographic separation was carried
out at 258C with a binary mobile phase system using a linear
gradient (HPLC buffer B 10% for 1 minute, 10%–100% for
10 minutes, 100% for 3 minutes).
Tandem mass spectrometry was carried out on a Q-Trap
5500 mass spectrometer (AB Sciex, Darmstadt, Germany)
equipped with an electrospray ionization interface. The
instrument was operated in the positive ionization mode at
+5500 V and a temperature of 5508C. Two specific multiple
reaction–monitoring transitions were optimized for all analytes
(Table 1).
Validation Parameters
Validation of the method was performed according to
the international guidelines using Valistat 1.0.39 Positive con-
trol samples were prepared of blank hair spiked at different
concentration levels (4–100 pg/mg for cortisone and cortisol,
1–20 pg/mg for AEA and 20–1000 pg/mg for 2AG), which
were processed in duplicate on 3 different days. The method
was validated for the following parameters: sensitivity [limits
of detection (LODs) and limits of quantification], linearity,




Analyte concentrations of each segment are shown in
Table 3.
A decrease of corticosteroid concentrations was observed
in all samples from proximal to distal segments. The possibility
to get more information about the intraindividual magnitude of
washout effects was given due to monthly sampling. Figure 1
shows a comparison of 1 particular hair segment, which was
grown in September and October 2011 (second–third month of
pregnancy) and collected at different times, as a model of the
hair age–dependent decrease of hair concentrations. For both
corticosteroids, the originally incorporated concentrations
decreased by .50% after 4 months of hair growth.
Alternatively, an individual comparison of proximal hair
segments—which are subjects of moderate washout only—
should be preferred. Evaluation of these segments collected
every month shows a significant increase of the corticosteroid
concentrations during pregnancy (Fig. 2). The highest concen-
trations of cortisol (13.4 pg/mg) and cortisone (45.7 pg/mg)
were measured for the proximal segment of the sample taken at
the fifth week postpartum. This hair segment reflects the time
from April to May 2012, the last month of pregnancy, and
the first month after delivery. Corticosteroid concentrations
decreased again after childbirth (first 2-cm segment of the
sample taken 9 weeks postpartum).
Profile of Endocannabinoids
In the case of our prospective study, AEA and 2AG
values were measured (Table 3). AEA concentrations vary
between 1.6 and 4.0 pg/mg (median: 2.6 pg/mg). Figure 3
shows the hair age–dependent change of AEA and 2AG con-
centrations of the corresponding hair segments that reflect the
period of September and October 2011. An elevation of con-
centrations with increasing age of hair is clearly visible for
TABLE 1. Optimum Ionization and Fragmentation Conditions
for Corticosteroids and Endocannabinoids: Q1, Q3, DP, and CE
Analyte Q1 (Da) Q3 (Da) DP (V) CE (eV)
Cortisol 363.2 267.1 90 27
309.1 90 24
Cortisone 361.2 163.1 55 33
121.1 55 43
Cortisol-d4 367.2 121.1 85 31
AEA 348.2 287.1 61 17
62.1 61 12
2AG 379.2 287.1 61 21
269.1 61 25
PEA 300.2 62.1 230 22
283 230 21
OEA 326.2 62.1 240 55
55.1 240 22
SEA 328.2 62.1 235 22
57.1 235 55
AEA-d8 356.2 294.1 61 17
CE, collision energy; DP, declustering potential; Q1, precursor ion; Q3, fragment ion.
TABLE 2. Validation Results of the LC–MS/MS Method for Measurement of Corticosteroids and Endocannabinoids











(pg/mg) Middle* Low* Middle* High* Low* Middle* High*
Cortisol 363.2 5.94 1.6 3.1 0.999 Linear 88 18.2 7.1 3.4 19.6 8.7 3.2
Cortisone 361.2 6.02 2.1 3.7 0.998 Linear 105 7.4 7.0 3.8 14.6 7.6 20.6
AEA 348.2 10.56 0.3 1.1 0.997 Linear 116 12.4 7.0 5.0 19.4 21.3 21.7
2AG 379.2 11.06 15 35 0.989 Linear 79 15.7 6.5 8.5 15.9 22.1 24.3
*Concentration value: low, 6 pg/mg for cortisone/cortisol; 2 pg/mg for AEA; 20 pg/mg for 2AG; middle, 20 pg/mg cortisone/cortisol; 6 pg/mg for AEA; 200 pg/mg for 2AG; high,
100 pg/mg for cortisone/cortisol; 20 pg/mg for AEA; 1000 pg/mg for 2AG.
LOQ, limit of quantification.
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2AG. In contrast, AEA concentrations remained constant and
did not change during the aging of hair.
AEA and 2AG concentrations in proximal segments
grown in the first to second trimester of pregnancy tend to be
increased (Fig. 4). The value of 2AG increases by 100% for
the first month of pregnancy and returned to the baseline
levels at the end of pregnancy.
In addition, the endocannabinoids N-palmitoyletha-
nolamine (PEA), N-oleoylethanolamine (OEA), and
N-stearoylethanolamine (SEA) were monitored. Their hair
TABLE 3. Hair Concentrations of Corticosteroids and





Cortisol Cortisone 2AG AEA
1. Sixth week of
pregnancy
1 5.1 14.6 266.9 1.9
2 3.9 11.1 260.1 1.7
3 2.9 6.9 261.4 1.7
4 ,LOD 5.5 432.5 1.9
2. 12th Week of
pregnancy
1 4.5 19.7 518.0 2.6
2 3.8 11.9 495.7 3.3
3 4.2 6.0 400.2 2.9
4 ,LOD 5.4 580.0 3.0
3. 17th Week of
pregnancy
1 6.2 20.0 444.6 2.7
2 4.6 10.8 762.4 4.0
3 2.8 7.5 701.8 3.7
4 1.9 4.7 646.6 3.0
4. 21st Week of
pregnancy
1 5.2 19.8 330.2 2.5
2 2.1 10.8 701.4 3.0
3 ,LOD 7.0 715.2 2.8
4 ,LOD 4.0 566.7 2.9
5. 25th Week of
pregnancy
1 6.0 23.1 374.4 2.0
2 4.5 13.2 644.3 2.6
3 3.4 8.4 888.3 2.7
4 ,LOD 7.1 655.3 2.8
6. 30th Week of
pregnancy
1 6.9 24.8 326.4 1.9
2 4.8 17.3 604.2 2.5
3 4.1 9.3 812.9 3.1
4 ,LOD 5.7 702.8 2.8
7. 34th Week of
pregnancy
1 7.4 29.6 356.4 1.7
2 4.5 16.6 662.8 2.6
3 3.6 9.8 782.4 2.9
4 ,LOD 5.5 650.4 ,LOD
8. 38th Week of
pregnancy
1 4.9 30.6 332.9 1.9
2 5.3 22.5 494.0 2.3
3 3.1 13.6 681.6 2.9
4 ,LOD 9.4 806.8 2.2
9. First week
postpartum
1 8.7 39.6 434.8 1.6
2 6.1 22.1 635.8 2.4
3 4.0 13.8 787.4 2.0
4 ,LOD 7.6 934.2 ,LOD
10. Fifth week
postpartum
1 13.4 45.7 365.2 2.0
2 7.0 28.7 635.6 1.8
3 5.3 17.4 1106.7 2.1
4 ,LOD 10.2 911.4 2.1
5 ,LOD 7.5 592.2 1.9
11. Ninth week
postpartum
1 8.8 27.6 256.6 2.1
2 7.3 27.8 477.2 2.7
3 3.8 16.8 699.3 3.4
4 ,LOD 9.0 816.1 2.7
5 ,LOD 6.8 768.1 2.9
FIGURE 1. Changes of the corticosteroid concentrations in
corresponding hair segments, which were grown in the same
time span (September to October 2011). Sampling was
accomplished every other month, and an offset of 2 cm was
applied to select corresponding growth cycles, an average of
1 cm/mo was assumed. The confidence intervals show the
consequence of an altered hair growth (range, 0.8–1.5 cm/mo).
The significant reduction of steroid concentrations in equivalent
segments indicates the washout of cortisol and cortisone,
respectively.
FIGURE 2. Cortisol and cortisone concentrations of the proxi-
mal segments of all hair samples taken monthly and collected
during pregnancy. Each segment has a length of 2 cm and
reflects the average of the previous 2 months, 1 month over-
lapping with the previous and subsequent sample. Concentra-
tion increase toward the end of pregnancy can clearly be seen.
After childbirth [sample which was taken 9 weeks postpartum
(pp)], the corticoid concentrations decrease again.
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concentrations were found to be 2–3 decades larger than that of
AEA, and strong mutual correlations between concentrations of
PEA, OEA, and AEA (P , 0.001) but no correlation between
SEA and AEA (Fig. 5) exist.
Correlation of Corticosteroids
and Endocannabinoids
Negative correlations (P , 0.001) between AEA and
cortisol and cortisone are visible for the hair samples of
our prospective study. Also, a weak negative correlation
(P , 0.01) can be shown between 2AG and the corticoste-
roids (Figs. 6A, B).
DISCUSSION
Based on the variations of analyte concentrations along
the hair shaft this study was designed to provide a separate
evaluation of the effects of washout and physiological
changes due to pregnancy on the hair concentrations of
corticosteroids and endocannabinoids. Conclusions from two
different points of view were possible by monthly sampling.
1. At first, comparisons of selected hair segments, which
were grown in a specific time and taken after different
periods of growth, became available. Thereby the washout
could be evaluated.
2. Second, the comparison of the proximal hair segments
during pregnancy demonstrated the physiological effects.
According to our previous experiments, a decrease of
corticosteroid concentrations along the hair shaft was
observed in our prospective study. During our routine
analysis, cortisol and cortisone were proved in 91% of the
cases. Three 3-cm segments were analyzed, and the cortico-
steroid concentrations were reduced between adjacent seg-
ments. The cortisol decrease was 37% (median; range, 5%–
73%) from the proximal to the second segment and 41%
(median; range, 4%–71%) from the second to the third seg-
ment. The cortisone concentrations reduced by 41% (median;
range, 16%–74%) and by 48% (median; range, 23%–76%)
between contiguous segments. These decreasing concentra-
tions along the hair strand are assumed to be mainly the
consequence of a washout effect. Due to the lack of an alka-
line function in the molecules, cortisol and cortisone are not
able to bind to the hair pigment melanin located in the cortex
(for details, see Refs 40242). Consequently, a loss of the
FIGURE 3. Changes of endocannabinoid concentrations in
corresponding hair segments (grown in September and
October 2011) after various hair growth times. 2AG shows in
general an increase with increasing age, whereas the AEA
levels do not change with the aging of hair.
FIGURE 4. AEA and 2AG concentrations of the proximal seg-
ments of all 11 hair samples taken during pregnancy. Each
segment has a length of 2 cm reflecting the last 2 months
before sampling with monthly overlapping. AEA and 2AG tend
to be increased at the second trimester of pregnancy. pp,
postpartum.
FIGURE 5. Mean hair profile of the endocannabinoids AEA, PEA,
SEA, and OEA. Shown are the area ratios to the IS. AEA is 2–3
decades lower than are the other endocannabinoids. A strong
correlation exists between PEA and OEA (r = 0.858) and PEA and
AEA (r = 0.692).
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substances may occur by washout effects, for example, cos-
metic treatment (permanent waving, dyeing), or leaching out
caused by mechanical damages of the hair structure.43,44 The
washout was also observed by several others9,19,21,45 but not
by all46,47 groups. Manenschijn et al46 assumed that washout
of steroids results from hair sample decontamination steps
before analysis. Opposed to this assumption, our studies show
that a decrease of corticosteroid concentration from distal to
proximal hair segment is also present without a decontamina-
tion step during sample preparation. Therefore, it seems to be
an effect due to aging of hair.
Moreover, it is apparently not possible to differentiate
between variations caused by washout effects and biochemical
influences, for example, increase of corticosteroids due to
stress based on a single sampling. The monthly sampling
permitted to monitor corticoid concentrations of hair segments
for a longer growth period. The older the respective hair
segment, the lower the detectable concentration of the cortico-
steroids. In the case of prospective study, the concentrations
have a half-time of approximately 4 months. According to self-
report, the hair washing did not change during the course of the
study. Therefore, the intensity of the washout seems to be
specific for this test person. Due to large interindividual
variations of the washout effect, it is not possible to calculate
the universal value for the significance, but the washout effect
should be taken into consideration when retrospective state-
ments are given.
The endocannabinoids show a different dependence on
the hair aging. The AEA concentrations seem to be unaffected
and stable. In consequence of the basic character (amid
group) of AEA, a stronger binding to the hair pigment
melanin is likely. Additional adsorption of AEA, for example,
by sebum or sweat, and washout, has only little influence on
the hair concentration. With regard to changes in 2AG
concentrations, our findings were different, however. The
older the respective hair segment, the higher the detectable
2AG concentration. This suggests that 2AG (similar to fatty
acid ethyl esters48) is partially incorporated into the hair via
passive diffusion from sebum or sweat.
The comparison of the proximal hair segments shows
the concentration changes were due to the physiological
variations during pregnancy. An increased concentration of
corticosteroids is clearly visible for the last months of
pregnancy and the first time after delivery. This concentration
profile is presumably the result of a chronic stress situation
during this time. According to other researchers,19221 our
results confirmed that this changed physiology is detectable
by consecutive hair tests.
Biochemical interactions of the corticosteroid and the
endocannabinoid system exist in human physiology. It was
assumed that the hair profiles of both analyte groups may
reflect the blood concentrations. An increase of AEA and
2AG was observed in the second trimester of pregnancy,
which shows the negative correlation to the corticosteroids. It
is conspicuous that the concentrations of the other endocan-
nabinoids are higher than that of the AEA. This is in contrast
to typical plasma concentration ratios. Therefore, a local
production in skin and/or predominant hair incorporation via
sweat and sebum seems to be likely.
CONCLUSIONS
Concentrations of several mediators of the corticoste-
roid and endocannabinoid systems in hair were examined
aiming to investigate their suitability for retrospective long-
term evaluations. In particular, their stability changes over
time during a stressful period in life, and potential correlation
between both systems were investigated.
The decrease of cortisol and cortisone concentrations
from proximal to distal segments of a hair strand, which is
mainly due to washout effects, is assumed to be a confounding
phenomenon. This was observed in a prospective study, which
allowed the subsequent examination of 1 particular hair segment
after 2, 4, 6, 8, and 10 months of growing. This washout of
corticosteroids is the subject of interindividual variations and
can—similarly to other neutral compounds, endogenous steroids
(androstenedione, testosterone), or polar compounds (ethyl glu-
curonide)—hardly be compensated or normalized.
Limiting measurements to proximal (0–3 cm) hair seg-
ments is essential to circumvent this problem and permits the
quantification of systematic (eg, stress-induced) long-term
variations.
FIGURE 6. Correlations of the hair concentrations of cortisone
with AEA and 2AG for the voluntary female during our pro-
spective study. A negative correlation exists between the hair
concentrations of cortisone and AEA (6A; r = 20.54) and also
between cortisone and 2AG (6B; r = 20.44).
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The endocannabinoids AEA and 2AG are other potent
markers for stress or inflammation, and serum concentrations
have been shown to reflect these conditions.49 However, their
interaction and correlation with corticosteroids are not fully
understood. The potential advantages of using hair to quantify
endocannabinoids are retrospection and stability. Endocanna-
binoids, which are easily hydrolyzed in blood and require con-
siderable analytical effort, seem to be rather stable in hair. In
particular, AEA seem to be unaffected by physical alterations,
for example, washout or passive adsorption. They could there-
fore be considered as potential complementary markers for
biochemical long-term effects. An increase of AEA and 2AG
in the second trimester of pregnancy was observed in the pro-
spective study. However, additional parameters with potential
influence on endocannabinoids, for example, nutrition, inflam-
mation, and drug effects need to be taken into account.
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